Singh, Puneet
Lim, Bora
Article History
Accepted: 16 September 2021
First Online: 3 February 2022
Declarations
:
: Puneet Singh declares that she has no conflict of interest. Bora Lim has received research funding from Puma Biotechnology, Novartis, Genentech, Merck, and Takeda Oncology. There are no directly relevant financial activities related to the drugs included in this article.